Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 5 other studies
18,192people with cardiovascular disease, aged 65+, in this paper
Among older adults without overt CVD (aged ≥65 years), the trial randomly assignedassigned by chance
statins
placebo
No clear effect on muscle-related symptoms+1%
randomisedthe abstract, start to end
… the risks of muscle-related symptoms (RR 1.01; 95% CI 0.90-1.12), total …
← favours treatmentfavours comparator →
could be chanceMuscle-related symptomsstatins vs placebo, in older adults without overt CVD (aged ≥65 years)
RR 1.010.90–1.12
StatinsAdverse events & safety
Statins × adverse events & safetyharms?mixed
unlikelylikely
0.16not counted
← favours comparatorfavours treatment →
1 / 6